Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Melanocytes | 5 | 2022 | 514 | 2.600 |
Why?
|
Neovascularization, Physiologic | 7 | 2021 | 1352 | 1.110 |
Why?
|
Interleukin-3 | 1 | 2023 | 441 | 0.830 |
Why?
|
Skin Pigmentation | 3 | 2022 | 281 | 0.710 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2020 | 137 | 0.680 |
Why?
|
Cytokines | 2 | 2023 | 7298 | 0.570 |
Why?
|
Dendritic Cells | 3 | 2023 | 2728 | 0.470 |
Why?
|
Proteoglycans | 2 | 2014 | 835 | 0.470 |
Why?
|
Neovascularization, Pathologic | 7 | 2014 | 2639 | 0.460 |
Why?
|
Vascular Endothelial Growth Factor A | 9 | 2021 | 3504 | 0.450 |
Why?
|
Extracellular Matrix Proteins | 2 | 2014 | 847 | 0.440 |
Why?
|
Chemokine CCL2 | 1 | 2014 | 618 | 0.410 |
Why?
|
Skin | 2 | 2022 | 4324 | 0.400 |
Why?
|
rhoB GTP-Binding Protein | 2 | 2013 | 16 | 0.350 |
Why?
|
Pigmentation | 2 | 2023 | 150 | 0.340 |
Why?
|
Angiogenesis Inducing Agents | 3 | 2017 | 283 | 0.260 |
Why?
|
Leishmaniasis, Visceral | 2 | 2003 | 93 | 0.250 |
Why?
|
Alkyl and Aryl Transferases | 1 | 2003 | 90 | 0.230 |
Why?
|
Inflammation | 3 | 2022 | 10534 | 0.230 |
Why?
|
Mice | 19 | 2023 | 81002 | 0.220 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2014 | 3863 | 0.220 |
Why?
|
Interleukin-5 | 1 | 2023 | 273 | 0.220 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3143 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3248 | 0.210 |
Why?
|
Receptor, Melanocortin, Type 1 | 1 | 2021 | 76 | 0.200 |
Why?
|
Mice, Inbred C57BL | 10 | 2021 | 21863 | 0.180 |
Why?
|
Endothelium, Vascular | 3 | 2013 | 4454 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8274 | 0.180 |
Why?
|
Animals | 23 | 2023 | 168368 | 0.170 |
Why?
|
Eosinophilia | 1 | 2023 | 531 | 0.160 |
Why?
|
Blood | 1 | 2021 | 597 | 0.160 |
Why?
|
Neuromyelitis Optica | 1 | 2022 | 249 | 0.160 |
Why?
|
Phlebotomus | 1 | 1998 | 8 | 0.160 |
Why?
|
Leishmania major | 1 | 1998 | 57 | 0.160 |
Why?
|
Capillary Permeability | 3 | 2016 | 799 | 0.150 |
Why?
|
Neuropilin-2 | 1 | 2016 | 54 | 0.140 |
Why?
|
Peptide Fragments | 2 | 2021 | 5076 | 0.140 |
Why?
|
Endothelial Cells | 6 | 2014 | 3435 | 0.140 |
Why?
|
Organ Specificity | 1 | 2021 | 2004 | 0.140 |
Why?
|
Arteries | 1 | 2021 | 1116 | 0.140 |
Why?
|
Ischemia | 2 | 2021 | 1908 | 0.120 |
Why?
|
Angiogenesis Inhibitors | 3 | 2010 | 2037 | 0.120 |
Why?
|
Micelles | 1 | 2015 | 207 | 0.120 |
Why?
|
Neuropilin-1 | 1 | 2014 | 91 | 0.120 |
Why?
|
Databases, Genetic | 1 | 2021 | 1777 | 0.120 |
Why?
|
NF-kappa B | 2 | 2014 | 2502 | 0.120 |
Why?
|
Disease Models, Animal | 5 | 2021 | 18003 | 0.120 |
Why?
|
Albinism, Oculocutaneous | 1 | 2013 | 17 | 0.110 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 12049 | 0.110 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1778 | 0.110 |
Why?
|
Monophenol Monooxygenase | 1 | 2013 | 70 | 0.110 |
Why?
|
Liver Regeneration | 1 | 2014 | 209 | 0.110 |
Why?
|
Peptides | 2 | 2017 | 4395 | 0.110 |
Why?
|
Cells, Cultured | 5 | 2014 | 19220 | 0.100 |
Why?
|
Lymphangiogenesis | 1 | 2013 | 170 | 0.100 |
Why?
|
Polyesters | 2 | 2015 | 367 | 0.100 |
Why?
|
Corneal Neovascularization | 1 | 2013 | 188 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 1 | 2003 | 4555 | 0.100 |
Why?
|
Drug Carriers | 1 | 2015 | 693 | 0.090 |
Why?
|
Lactic Acid | 1 | 2015 | 1132 | 0.090 |
Why?
|
Microcirculation | 1 | 2014 | 1285 | 0.090 |
Why?
|
Antigens, CD | 2 | 2012 | 4024 | 0.090 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2013 | 502 | 0.090 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2013 | 643 | 0.090 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2022 | 2091 | 0.090 |
Why?
|
Lymphedema | 1 | 2016 | 527 | 0.090 |
Why?
|
Polyethylene Glycols | 1 | 2015 | 1182 | 0.090 |
Why?
|
Mice, Inbred BALB C | 2 | 2016 | 6397 | 0.080 |
Why?
|
Intestine, Small | 1 | 2015 | 1242 | 0.080 |
Why?
|
Multipotent Stem Cells | 1 | 2010 | 185 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2020 | 2950 | 0.080 |
Why?
|
Cyclohexanes | 1 | 2008 | 153 | 0.080 |
Why?
|
Polymers | 1 | 2015 | 1616 | 0.080 |
Why?
|
Gene Expression | 1 | 2021 | 7788 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2009 | 2507 | 0.080 |
Why?
|
Cadherins | 2 | 2011 | 901 | 0.080 |
Why?
|
Thrombospondin 1 | 1 | 2009 | 250 | 0.080 |
Why?
|
Sesquiterpenes | 1 | 2008 | 176 | 0.080 |
Why?
|
Survival Analysis | 1 | 2020 | 10247 | 0.070 |
Why?
|
Hyperoxia | 1 | 2009 | 264 | 0.070 |
Why?
|
Doxycycline | 1 | 2008 | 327 | 0.070 |
Why?
|
Retinal Diseases | 1 | 2013 | 687 | 0.070 |
Why?
|
Humans | 21 | 2023 | 739398 | 0.070 |
Why?
|
Cell Movement | 3 | 2013 | 5221 | 0.070 |
Why?
|
Dexamethasone | 2 | 2010 | 1948 | 0.070 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2008 | 600 | 0.070 |
Why?
|
Signal Transduction | 3 | 2021 | 23355 | 0.060 |
Why?
|
Cell Adhesion | 1 | 2011 | 3137 | 0.060 |
Why?
|
Hemangioma | 1 | 2010 | 738 | 0.060 |
Why?
|
Glycoproteins | 1 | 2012 | 2259 | 0.060 |
Why?
|
Cell Proliferation | 4 | 2013 | 10455 | 0.060 |
Why?
|
Farnesyltranstransferase | 1 | 2003 | 76 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4463 | 0.060 |
Why?
|
Retinal Vessels | 1 | 2009 | 774 | 0.060 |
Why?
|
Collagen | 1 | 2011 | 2671 | 0.060 |
Why?
|
Israel | 2 | 2003 | 794 | 0.050 |
Why?
|
Neoplastic Stem Cells | 1 | 2010 | 1380 | 0.050 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2003 | 437 | 0.050 |
Why?
|
Apoptosis | 4 | 2022 | 9714 | 0.050 |
Why?
|
Aquaporin 4 | 1 | 2022 | 153 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2010 | 2100 | 0.050 |
Why?
|
Cornea | 1 | 2008 | 1488 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2021 | 11668 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2016 | 7862 | 0.040 |
Why?
|
Endometriosis | 1 | 2007 | 832 | 0.040 |
Why?
|
Administration, Oral | 3 | 2015 | 3909 | 0.040 |
Why?
|
Liver | 1 | 2014 | 7449 | 0.040 |
Why?
|
Cell Membrane | 1 | 2008 | 3747 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2277 | 0.040 |
Why?
|
Retina | 1 | 2009 | 2633 | 0.040 |
Why?
|
Dog Diseases | 1 | 1998 | 136 | 0.040 |
Why?
|
Lung Neoplasms | 3 | 2011 | 12985 | 0.040 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2016 | 226 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2010 | 13635 | 0.030 |
Why?
|
Rats | 2 | 2021 | 24270 | 0.030 |
Why?
|
Blotting, Western | 2 | 2014 | 5181 | 0.030 |
Why?
|
Antigens, Protozoan | 1 | 1998 | 322 | 0.030 |
Why?
|
Animals, Newborn | 2 | 2013 | 2732 | 0.030 |
Why?
|
Female | 9 | 2023 | 378853 | 0.030 |
Why?
|
Astrocytes | 1 | 2022 | 1258 | 0.030 |
Why?
|
Caco-2 Cells | 1 | 2015 | 387 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2003 | 2965 | 0.030 |
Why?
|
Intestinal Absorption | 1 | 2015 | 420 | 0.030 |
Why?
|
Autoantibodies | 1 | 2022 | 2020 | 0.030 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2014 | 1088 | 0.030 |
Why?
|
Risk Factors | 1 | 2020 | 71974 | 0.030 |
Why?
|
Protein Binding | 2 | 2017 | 9375 | 0.030 |
Why?
|
Perfusion | 1 | 2017 | 1354 | 0.030 |
Why?
|
Blotting, Northern | 1 | 2014 | 1583 | 0.030 |
Why?
|
Lymphatic Vessels | 1 | 2016 | 352 | 0.030 |
Why?
|
Male | 6 | 2023 | 349022 | 0.030 |
Why?
|
Catenins | 1 | 2011 | 40 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 2013 | 799 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2010 | 5632 | 0.020 |
Why?
|
Endocytosis | 1 | 2015 | 984 | 0.020 |
Why?
|
Blood Vessels | 1 | 2016 | 1126 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2014 | 1934 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4522 | 0.020 |
Why?
|
Hemangioma, Capillary | 1 | 2010 | 61 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2013 | 1837 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2021 | 8299 | 0.020 |
Why?
|
Galectin 3 | 1 | 2011 | 226 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11347 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-fyn | 1 | 2009 | 116 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2021 | 3620 | 0.020 |
Why?
|
Thrombospondins | 1 | 2009 | 195 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 29658 | 0.020 |
Why?
|
Adherens Junctions | 1 | 2008 | 89 | 0.020 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2010 | 240 | 0.020 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2008 | 115 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2011 | 2084 | 0.020 |
Why?
|
Hypersensitivity, Delayed | 1 | 2008 | 485 | 0.020 |
Why?
|
Phosphorylation | 2 | 2009 | 8416 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2013 | 2433 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2009 | 549 | 0.020 |
Why?
|
Boronic Acids | 1 | 2010 | 966 | 0.020 |
Why?
|
Prevalence | 1 | 2003 | 15153 | 0.020 |
Why?
|
Capillaries | 1 | 2009 | 767 | 0.020 |
Why?
|
Cell Transplantation | 1 | 2007 | 478 | 0.020 |
Why?
|
Pulmonary Edema | 1 | 2008 | 415 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2011 | 8400 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7136 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2007 | 545 | 0.020 |
Why?
|
Pyrazines | 1 | 2010 | 1232 | 0.020 |
Why?
|
Acetaminophen | 1 | 2008 | 541 | 0.010 |
Why?
|
Cell Lineage | 1 | 2013 | 2486 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2011 | 16646 | 0.010 |
Why?
|
Mice, Nude | 1 | 2010 | 3692 | 0.010 |
Why?
|
Base Sequence | 1 | 2014 | 12804 | 0.010 |
Why?
|
Down-Regulation | 1 | 2010 | 2999 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1998 | 14740 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2010 | 6310 | 0.010 |
Why?
|
Melanoma | 2 | 2012 | 5446 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9734 | 0.010 |
Why?
|
Wound Healing | 1 | 2013 | 2768 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2008 | 1883 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 18125 | 0.010 |
Why?
|
RNA Interference | 1 | 2010 | 2899 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2011 | 4832 | 0.010 |
Why?
|
Foxes | 1 | 1998 | 9 | 0.010 |
Why?
|
Carnivora | 1 | 1998 | 29 | 0.010 |
Why?
|
Leishmania infantum | 1 | 1998 | 17 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2010 | 2727 | 0.010 |
Why?
|
Cell Survival | 1 | 2009 | 5877 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 53037 | 0.010 |
Why?
|
Disease Reservoirs | 1 | 1998 | 131 | 0.010 |
Why?
|
Infant | 2 | 2010 | 34923 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12951 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10945 | 0.010 |
Why?
|
Antibodies, Protozoan | 1 | 1998 | 251 | 0.010 |
Why?
|
Oxygen | 1 | 2009 | 4158 | 0.010 |
Why?
|
Seroepidemiologic Studies | 1 | 1998 | 401 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2013 | 9622 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2010 | 13002 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2009 | 14558 | 0.010 |
Why?
|
Dogs | 1 | 1998 | 3915 | 0.010 |
Why?
|
Transcription Factors | 1 | 2013 | 12120 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2010 | 25470 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2007 | 11460 | 0.010 |
Why?
|
Middle Aged | 1 | 2023 | 212863 | 0.010 |
Why?
|
Child, Preschool | 1 | 2010 | 40802 | 0.000 |
Why?
|
Child | 2 | 2010 | 77033 | 0.000 |
Why?
|
Time Factors | 1 | 2009 | 40050 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2008 | 62693 | 0.000 |
Why?
|
Concepts
(204)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_